Company: ARMP
Filing Date: 2025-12-01
Form Type: 424B5
Source: 0001104659-25-117382
Chunk: 56

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 424B5
Chunk 56
---
 payable and 
 the regular record dates for interest payment dates or the method for determining such dates;                                          |

| · | whether or not the debt securities will be secured 
 or unsecured, and the terms of any secured debt;   |

| · | the terms of the subordination of any series 
 of subordinated debt;                        |

| · | the place where payments will be payable; |

| · | restrictions on transfer, sale or other assignment, 
 if any;                                             |

| · | our right, if any, to defer payment of interest     
 and the maximum length of any such deferral period; |

| · | the date, if any, after which the conditions                                                                                            
 upon which, and the price at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional 
 redemption provisions and the terms of those redemptions provisions;                                                                    |

| · | the date, if any, on which, and the price at                                                                                            
 which we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder’s 
 option to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable;           |

| · | whether the indenture will restrict our ability                                
 to pay dividends, or will require us to maintain any asset ratios or reserves; |

| · | whether we will be restricted from incurring                                                                                  
 any additional indebtedness, issuing additional securities, or entering into a merger, consolidation or sale of our business; |

| · | a discussion of any material or special United                              
 States federal income tax considerations applicable to the debt securities; |

| · | information describing any book-entry features; |

| · | provisions for a sinking fund purchase or other 
 analogous fund, if any;                         |

| · | any provisions for payment of additional amounts                                                                     
 for taxes and any provision for redemption, if we must pay such additional amount with respect to any debt security; |

<div align='center'>18</div>

| · | whether the debt securities are to be offered                                                                         
 at a price such that they will be deemed to be offered at an “original issue discount” as defined in paragraph (a) of 
 Section 1273 of the Internal Revenue Code;                                                                            |

| · | the denominations in which we will issue the                                                        
 series of debt securities, if other than denominations of $1,000 and any integral multiple thereof; |

| · | the terms on